0001104659-22-027392.txt : 20220225
0001104659-22-027392.hdr.sgml : 20220225
20220225171504
ACCESSION NUMBER: 0001104659-22-027392
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220225
DATE AS OF CHANGE: 20220225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rubin Jonathan
CENTRAL INDEX KEY: 0001836067
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 22681854
BUSINESS ADDRESS:
BUSINESS PHONE: 3018382500
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4/A
1
tm227764-2_4aseq1.xml
OWNERSHIP DOCUMENT
X0306
4/A
2022-02-22
2022-02-24
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001836067
Rubin Jonathan
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
0
1
0
0
SVP, Chief Medical Officer
Employee Stock Option (Right to Buy)
32.20
2022-02-22
4
A
0
25000
0
A
2032-02-22
Common Stock
25000
25000
D
Restricted Stock Units
2022-02-22
4
A
0
3000
0
A
Common Stock
3000
3000
D
The option vests in four equal annual installments beginning on February 22, 2023.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023.
/s/ Timothy C. Dec, as attorney-in-fact
2022-02-25